Rocuronium and sugammadex: An alternative to succinylcholine for electro convulsive therapy in patients with suspected neuroleptic malignant syndrome

We report a case of presumptive neuroleptic malignant syndrome requiring muscle relaxation for electro-convulsive therapy. short acting muscle relaxation without the use of succinylcholine was achieved using rocvronivm reversed with the novel reversal agent sugammadex. We suggest that this combinati...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramamoorthy, Karthik G., Downey, H, Hawthorne, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications Pvt Ltd 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161467/
https://www.ncbi.nlm.nih.gov/pubmed/21897513
http://dx.doi.org/10.4103/0970-9185.83687
_version_ 1782210703072952320
author Ramamoorthy, Karthik G.
Downey, H
Hawthorne, P
author_facet Ramamoorthy, Karthik G.
Downey, H
Hawthorne, P
author_sort Ramamoorthy, Karthik G.
collection PubMed
description We report a case of presumptive neuroleptic malignant syndrome requiring muscle relaxation for electro-convulsive therapy. short acting muscle relaxation without the use of succinylcholine was achieved using rocvronivm reversed with the novel reversal agent sugammadex. We suggest that this combination is a safe and effective alternative to succinylcholine in such cases.
format Online
Article
Text
id pubmed-3161467
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-31614672011-09-06 Rocuronium and sugammadex: An alternative to succinylcholine for electro convulsive therapy in patients with suspected neuroleptic malignant syndrome Ramamoorthy, Karthik G. Downey, H Hawthorne, P J Anaesthesiol Clin Pharmacol Case Report We report a case of presumptive neuroleptic malignant syndrome requiring muscle relaxation for electro-convulsive therapy. short acting muscle relaxation without the use of succinylcholine was achieved using rocvronivm reversed with the novel reversal agent sugammadex. We suggest that this combination is a safe and effective alternative to succinylcholine in such cases. Medknow Publications Pvt Ltd 2011 /pmc/articles/PMC3161467/ /pubmed/21897513 http://dx.doi.org/10.4103/0970-9185.83687 Text en © Journal of Anaesthesiology Clinical Pharmacology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Ramamoorthy, Karthik G.
Downey, H
Hawthorne, P
Rocuronium and sugammadex: An alternative to succinylcholine for electro convulsive therapy in patients with suspected neuroleptic malignant syndrome
title Rocuronium and sugammadex: An alternative to succinylcholine for electro convulsive therapy in patients with suspected neuroleptic malignant syndrome
title_full Rocuronium and sugammadex: An alternative to succinylcholine for electro convulsive therapy in patients with suspected neuroleptic malignant syndrome
title_fullStr Rocuronium and sugammadex: An alternative to succinylcholine for electro convulsive therapy in patients with suspected neuroleptic malignant syndrome
title_full_unstemmed Rocuronium and sugammadex: An alternative to succinylcholine for electro convulsive therapy in patients with suspected neuroleptic malignant syndrome
title_short Rocuronium and sugammadex: An alternative to succinylcholine for electro convulsive therapy in patients with suspected neuroleptic malignant syndrome
title_sort rocuronium and sugammadex: an alternative to succinylcholine for electro convulsive therapy in patients with suspected neuroleptic malignant syndrome
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161467/
https://www.ncbi.nlm.nih.gov/pubmed/21897513
http://dx.doi.org/10.4103/0970-9185.83687
work_keys_str_mv AT ramamoorthykarthikg rocuroniumandsugammadexanalternativetosuccinylcholineforelectroconvulsivetherapyinpatientswithsuspectedneurolepticmalignantsyndrome
AT downeyh rocuroniumandsugammadexanalternativetosuccinylcholineforelectroconvulsivetherapyinpatientswithsuspectedneurolepticmalignantsyndrome
AT hawthornep rocuroniumandsugammadexanalternativetosuccinylcholineforelectroconvulsivetherapyinpatientswithsuspectedneurolepticmalignantsyndrome

Ejemplares similares